Daratumumab Plus VRd for Multiple Myeloma | NEJM
Автор: NEJM Group
Загружено: 2024-01-25
Просмотров: 4824
New multiple myeloma treatments are needed to attain long-term disease control. Adding the monoclonal antibody daratumumab to standard therapy has shown potential for improving outcomes.
New research findings are summarized in a short video.
To see the full article, follow this link: https://nej.md/3Nm3j33
#cancerresearch #clinicaltrials #medicaleducation #oncology #nejm
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: